Days before Manipal Health Enterprises' IPO opens, a dispute with US-based minority shareholders of its Kolkata subsidiary has resurfaced. The investors allege the company failed to honour a promised 15% annual compounded return, diluted their holdings through later corporate actions, and withheld key information. They have also challenged changes to their shareholder status.